INSIGHTS ON DRUG DEVELOPMENT

• Asymchem's Green Commitment

  See how advanced reaction technologies — flow chemistry, photochemistry, and biocatalysis — boost efficiency, improve safety, and cut environmental impact, enabling more sustainable development practices.

• Can Collaboration Close Biopharma's Talent Gap For Good?

  Biopharma innovation is accelerating, but workforce shortages threaten progress. See how strengthening collaboration is essential to developing the skills needed for emerging therapies.

• Bioprocess Training And Education

  Advance from development to manufacturing with expert-led, hands-on, or virtual courses that strengthen process understanding and scale-up skills designed to support every stage of your molecule’s journey.

• Right From The Start: Smarter Developability For Stronger Formulations

  Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.

• Maximizing Laboratory Efficiency With Automated Dual-Thermal Cycling

  3/26/2026

  Accelerate tRNA lead discovery with automated digital PCR. Process 384 samples daily with minimal hands-on time, using dual thermal cyclers to scale from in vitro screening to clinical trials.

• Nitrosamine Testing: How To Ensure Regulatory Compliance, Product Safety

  9/16/2025

  Explore what nitrosamines are, why testing matters, and how we're able to deliver high-confidence solutions through advanced science and industry-leading expertise.

• Managing Process Knowledge Throughout Drug Development And Manufacturing

  10/21/2025

  Discover how digitalizing recipe and risk management helps life sciences teams accelerate drug development, streamline technology transfers, and simplify compliance to improve data integrity.

• Navigating Preclinical Drug Development Challenges With Lipid-Based Formulations

  3/20/2026

  Maximize the oral bioavailability of challenging small-molecule candidates and streamline the path from preclinical toxicology to clinical trials by leveraging optimized lipid-based formulations.

• A Case Study Of The GLP-1 Receptor Agonist, Semaglutide, In Plasma

  7/31/2025

  Light scattering reveals critical insights into the structural integrity, aggregation, and stability of GLP-1 analogs, which are essential for optimizing drug formulations and improving treatments.